Table 2.

Differences in patient characteristics between responders and non-responders

	responder [n = 206]	Non-responder [n = 220]	P-value
Age (mean ± SD)	64 [10]	60 [12]	0.002
Gender (N [%])
Male	120 [58]	129 [59]	0.93
Female	86 [42]	91 [41]
Education level (N[%])
Primary	52 [26]	67 [32]	0.43
Secondary	80 [41]	81 [39]
University	66 [33]	62 [29]
Labour (N [%])
Paid labour	49 [25]	68 [33]	0.08
Unemployed	55 [28]	64 [31]
Retired	94 [47]	77 [36]
Country of origin is the Netherlands(N[%])
Yes	174 [88]	181 [86]	0.62
No	24 [12]	29 [14]
Reason referral (N[%])			0.89
acute coronary syndrome	34 [16]	37 [17]
peripheral arterial disease	47 [23]	46 [21]
stroke/TIA	125 [61]	137 [62]
Blood pressure (mmHg; mean ± SD)
Systolic	140 [±19]	142 [±20]	0.30
Diastolic	78 [±11]	79 [±10]	0.23
Body Mass Index (mean ± SD)	26 [±4]	26 [±4]	0.22
Waist (mean ± SD)
Male	97 [±11]	99 [±12]	0.16
Female	91 [±13]	89 [±13]	0.36
Lipids (mmol/ltr; mean ± SD)
Totaal cholesterol	4.6 [±1]	4.6 [±0.9]	0.73
Triglyceriden	1.7 [±1]	1.7 [±0.9]	0.01
HDL	1.3 [±0.3]	1.2 [±0.3]	0.06
LDL	2.5 [±0.9]	2.6 [±0.9]	0.78
Medication(N [%])
Antithrombotic agents [ATC B01]	196 [97]	213 [98]	0.27
Diuretics [ATC C03]	62 [31]	56 [26]	0.28
Beta Blocking agents [ATC C07]	93 [46]	96 [44]	0.74
Calcium channel blockers [ATCC08]	30 [15]	34 [16]	0.80
Agents acting on [..] system [ATC C09]	98 [48]	80 [37]	0.02
Lipid modifying agents [ATC C10]	166 [82]	173 [80]	0.59